A systematic review of post-liver transplantation treatment and outcomes for late T-cell mediated, chronic ductopenic, and antibody-mediated rejection
Higher-quality and contemporaneous data are needed to apply uniform definitions for treatment response rates and standardized treatment regimens. Regimens warranting further study include increasing baseline immunosuppression for late T-cell-mediated rejection and mTOR inhibitors for treating chronic ductopenic rejection.
Authors
- D. Vrochides
- T. Schiano
- Demetris Aj
- Kwo P
- Helen S. Te
- Mark W. Russo
- Yianni Protopapadakis
Institutions
- University of Pittsburgh (US)
- Carolinas Medical Center (US)
- University of Illinois Chicago (US)
- University of Chicago (US)
- Mount Sinai Hospital (US)
- Atrium Medical Cente (US)
- University of Pittsburgh Medical Center (US)
- Stanford University (US)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1097/hc9.0000000000000906
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00